Shortage of essential medical supplies in Democratic Republic of Congo (DRC) jeopardizes the survival of the most vulnerable amidst a fragile peace process, warns International Rescue Committee (IRC)
Over 72,000 people reached by the IRC's humanitarian programming in eastern DRC are now at risk due to dwindling supplies and funding.
Health facilities are overwhelmed, with many unable to provide basic services like nutrition, primary care, and reproductive health.
Medical supplies are running low, leaving survivors of sexual violence and thousands of children without critical care.
Stockouts of therapeutic milk have been reported in several health zones, compromising treatment for children with severe acute malnutrition.
Humanitarian response is critically underfunded: Only 9% of the Humanitarian Response Plan has been funded as of April 2025.
As talks advance towards a potential peace agreement in eastern Democratic Republic of Congo (DRC), the International Rescue Committee (IRC) warns of critical medical shortages, leaving thousands who are already vulnerable without access to essential assistance, especially in services addressing acute malnutrition and support for survivors of sexual violence.
The IRC's response to the latest humanitarian crisis has to date reached over 72,000 people. Lack of essential medicines, limited humanitarian access, and dwindling funding puts the continuity of this response, and the lives of displaced populations, at serious risk.
Health facilities across North and South Kivu are overwhelmed and running out of supplies, with many no longer able to provide essential services, including primary health care, nutrition support, and sexual and reproductive health care. At Hebron Health Center in the Karisimbi Health Zone, for example, IRC staff report having to turn away survivors of sexual violence due to a shortage of medicines that are taken after a possible exposure to prevent HIV infection and unwanted pregnancy. Referrals to other clinics are futile given stocks across the entire country are dangerously low.
Therapeutic milk stocks to treat children with the deadliest form of malnutrition have run out in several health zones, seriously compromising the treatment of children suffering from severe acute malnutrition.
Dr. Lievin Bangali, IRC's Senior Health Coordinator in DRC, said:
"The situation is heartbreaking. This breakdown comes at a time when the number of cases of sexual-based violence is rising dramatically, despite many cases going unreported . Every time supplies run out or aid provision is delayed, children's lives are put at risk, survivors of sexual violence are left without support, and public health worsens.
Our health centers in Goma are dangerously short of vaccines for children and our current stocks of essential medicines are already running low. For example, we have no more anti-malaria drugs or antibiotic syrups. Thousands of children are therefore at risk of dying without appropriate treatment.
The IRC remains committed to continuing its efforts in supporting vulnerable communities in the DRC. We urge the removal of barriers to humanitarian access to restore vital supply chains, and call on partners to provide immediate funding for nutrition, primary health, vaccination, and protection efforts to prevent further loss of life.'
The collapse of the medical infrastructure is driven by security constraints in health zones where access to humanitarian aid is limited, compounded by ongoing airport closures and a sharp decline in already insufficient humanitarian funding. The disruption of vaccine supplies further hinders the recovery of children who are out of sync with the vaccination schedule or under-vaccinated, leading to a rise in preventable deaths.
Despite these escalating needs, the humanitarian response remains critically underfunded. As of April 2025, the Humanitarian Response Plan is only 9% funded. The IRC calls on public donors to prioritize funding for the response plan to be able to support thousands of people in need of humanitarian assistance. DRC is one of the most vulnerable countries to the global reduction in aid budgets due to the level of humanitarian need, reliance on grant-based funding, level of debt distress, and exposure to the climate crisis.
Distributed by APO Group on behalf of International Rescue Committee (IRC) .
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arabian Post
3 days ago
- Arabian Post
HKSTP Teams Up with HKU and CUHK Medical Schools to Showcase Hong Kong's Life & Health Innovations at BIO International Convention
Seizing Global Business and Investment Opportunities for Sustainable Growth HONG KONG SAR – Media OutReach Newswire – 17 June 2025 – Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with InvestHK, led 16 prominent life and health technology companies to BIO 2025, the world's largest biotechnology event, held in Boston, USA, from June 16 to 19. This year marks the first time HKSTP joined forces with Hong Kong's two leading medical faculties—the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) – to form a delegation, showcasing Hong Kong's cutting-edge research capabilities and innovation potential in life sciences and health technologies. The initiative further strengthens Hong Kong's position as a world-class biotech innovation hub. In collaboration with InvestHK, HKSTP joined forces with the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) for the first time to form a delegation and led 16 prominent life and health technology companies to showcase at BIO 2025 held in Boston, USA. The HKSTP Pavilion highlighted the groundbreaking technologies and products of its park companies, featuring innovative solutions across diverse fields such as novel drug development, diagnostic technologies, and medical innovation. Among the 16 participating companies, they were the members of HKSTP's incubation programmes including Incu-Bio and ELITE Programme, cutting-edge work from the InnoHK research centers, and other outstanding biotech companies. On the first day of the exhibition, the delegation successfully attracted attention from global industry leaders, corporate partners, and venture capital firms. ADVERTISEMENT During BIO 2025, HKSTP and its park companies made significant strides in fostering cross-border innovation ecosystems and exploring new market opportunities: Immuno Cure , partnering with HKUMed, the developer of the first-in-human novel therapeutic HIV vaccine ICVAX, announced its collaboration with PharmaJet to explore the application of a needle-free vaccination solution, accelerating the global commercialization pathway for ICVAX. , partnering with HKUMed, the developer of the first-in-human novel therapeutic HIV vaccine ICVAX, announced its collaboration with PharmaJet to explore the application of a needle-free vaccination solution, accelerating the global commercialization pathway for ICVAX. HKSTP signed a partnership agreement with DLRC to provide legal advisory services in clinical trials and certification, promoting global ecosystem collaboration and growth. Mr. Albert Wong, CEO of HKSTP, said: 'We are thrilled to partner with two leading medical schools for the first time at BIO 2025, demonstrating Hong Kong's breakthroughs and innovation in life and health technology. This delegation not only deepens collaboration between Hong Kong and top global research institutions but also highlights our unique advantages as a core I&T hub in the Greater Bay Area. With strong policy and funding support from the HKSAR government, Hong Kong will further serve as a bridge connecting Mainland China and global tech partnerships, solidifying its leadership in life sciences innovation.' Ahead of BIO 2025, the delegation participated in the '2025 Biomedical Pitch Competition', co-organized by the Boston Capital Investment Club (BCIC) and HKSTP. The event connects global life and health innovators with investors and business partners. Three HKSTP companies—ARBELE, GenEditBio, and Cogsmart—excelled in the preliminary rounds, competing against over 100 global life sciences firms, with ARBELE, HKUMed's affiliated spin-off company, winning the championship, underscoring Hong Kong's research excellence. Over the past three years, this platform has helped startups secure over USD 100 million in funding and connect with hundreds of international investors and partners, driving further business growth. HKSTP is committed to propelling Hong Kong's life sciences sector onto the global stage, showcasing the city's unique strengths to attract international enterprises and talent. The delegation also organized networking events and visits, enabling Hong Kong companies to engage with overseas investors, leading corporations, and renowned academic institutions, including visits to MIT Professor Robert Langer (Described as 'Edison of Medicine'), Harvard Innovation Labs, Cambridge Innovation Center, and more. This initiative reinforces Hong Kong's sustainable development in life sciences and its role as a global innovation leader. Appendix: List of Park Companies Participating in BIO 2025: ADVERTISEMENT Allegrow Biotech Limited ARBELE Limited Beth Bioinformatics Co., Limited Centre for Translational Stem Cell Biology The Centre for Virology, Vaccinology, and Therapeutics DECODE CURE Limited GenEditBio Limited Great Bay Bio Hong Kong Universal Biologicals Company Limited Immuno Cure Holding (HK) Limited The Institute for Innovation, Translation and Policy Research (ITPR) LEE'S PHARMACEUTICAL (HK) LIMITED Serilink Biotechnology Company Limited Xiaomo Biotech Limited XUXIN (HongKong) Biotechnology Co., Limited Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited Hashtag: #HKSTP The issuer is solely responsible for the content of this announcement. About Hong Kong Science and Technology Parks Corporation Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, more than 15,000 research professionals and over 2,300 technology companies from 25 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc. Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined. Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more. Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in stablishing I&T as a pillar of growth for Hong Kong. More information about HKSTP is available at
Zawya
03-06-2025
- Zawya
Mozambique: Human Immunodeficiency Virus (HIV) Services Expand to Reach People with Disabilities
Across Mozambique, momentum is building in the delivery of HIV services, bringing renewed opportunities for communities that have long been on the margins. In Beira, one organization is working to ensure that people with disabilities are fully supported in the country's response to HIV. AMAMUS, a local group funded through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), has emerged as a key partner in expanding access to HIV prevention, testing and treatment. Drawing on trusted community ties, the organization quickly ramped up its services earlier this year, reaching both new and existing beneficiaries through tailored approaches. Antonia Piri Piri, AMAMUS Coordinator and a respected advocate who also lives with hearing impairment said that they were ready to reach out to beneficiaries who depend on them not only for healthcare but also for reassurance, understanding, and a sense of connection. She added that as soon as it was possible, they returned to the neighborhoods to ensure that no one was left behind. Bringing Services Closer to Those Often Overlooked In Mozambique, roughly 2% of the population lives with a disability—a group that routinely faces barriers in the health system. The 2017 census found that 9.4% of people with disabilities have hearing impairments, with more than 14,000 living in Sofala Province, where AMAMUS is most active. One of the many touched by the organization's work is Joana Antonio, 26. Blind since childhood, Joana had never taken an HIV test due to fear, misinformation, and the lack of accessible information. With guidance from AMAMUS, she used a self-test kit for the first time and learned she was living with both HIV and tuberculosis. She was quickly linked to treatment and continues to receive support. Joana said that although she was initially scared to find out her status, she received support and guidance from AMAMUS, which helped her understand everything. She now knows her status and is receiving the care she needs. Privacy, Dignity and Health at Home A central part of AMAMUS's outreach is the promotion of HIV self-testing, an empowering tool for individuals who face obstacles visiting health centers. The kits are distributed through door-to-door outreach, community visits, and awareness sessions, where AMAMUS activists demonstrate how to use them safely and privately. For people with disabilities, this approach removes hurdles like long travel, communication barriers, and the need for intermediaries. If a test is positive, AMAMUS steps in to provide counseling, confirmatory testing, and referrals to care. They also offer psychosocial support and help escort individuals to clinics when needed. Creating a Health System That Reflects Everyone Despite progress, structural challenges persist. Many health facilities are not adapted for those with mobility, visual, or auditory impairments. Public transportation remains inconsistent and discriminatory, sometimes charging extra for assistive devices or refusing service altogether. These gaps hinder consistent access to treatment and increase the risk of drug resistance. AMAMUS is working to overcome these hurdles by advocating for more representation in health planning and by adapting their own services to meet people where they are. For AMAMUS, this is about more than just physical access—it's about visibility, voice, and respect. Tech Tools Build Community Engagement AMAMUS is also using digital tools to build stronger connections. The organization created WhatsApp groups tailored to different communities, providing real-time updates on HIV services and creating a space for peer support. A community health fair is also in the works, designed to bring integrated services like HIV testing directly to residents in hard-to-reach areas. Progress Anchored in Community Strength As Mozambique intensifies its HIV response, organizations like AMAMUS are playing a vital role in ensuring that services reach all corners of society. Their work is helping to dismantle long-standing barriers and foster broad-based participation in health initiatives. While a temporary pause in activities earlier this year posed logistical challenges, it also reinforced the value of community-rooted responses and the urgency of building health systems that serve everyone, regardless of ability or background. Distributed by APO Group on behalf of U.S. Embassy in Mozambique.
Zawya
03-06-2025
- Zawya
South Africa: Lesotho's health system has been decimated by US funding cuts
In March, Lesotho's health minister Selibe Mochoborane boldly stated that the country's HIV response will survive without support from the US. The US model was ' too expensive ', he said, and methods would have to be adapted 'to align with our available resources". He was confident that Lesotho would still reach its ambitious HIV prevention and treatment targets by 2030. But senior health officials seemed less confident while presenting to Parliament's portfolio committee on pandemics last week. 'When you cut community HIV prevention services, you inevitably increase new infections,' said Tapiwa Turambiswa, who manages the Ministry of Health's HIV/Aids programmes. Pepfar distributes its funds in Lesotho via the United States Agency for International Development (USAid) and the US Center for Disease Control (CDC). Turambisa said that 93% of USAid's funding and 6% from the CDC has been cut. In total, funding from USAid and the CDC has been slashed from about R1.4bn to R600m. 652 frontline workers have lost their jobs due to the cuts. The country has lost 60% of its counsellors who were providing HIV testing services, said Turambiswa. This will decrease the number of people tested, increasing the number of people unknowingly spreading the virus, he said. In August last year, 11,702 people were tested but in April this year, only 9,054 were tested. Llang Mamma, the ministry's national TB programme manager, said that many people diagnosed with TB are not being tested for HIV as per government policy, because of staff shortages. 'That means we will delay detection of new infections and related treatment,' Maama said. Donor-dependent Of the country's M2.2bn (one loti, M, is equal to one rand, R) health budget last year, only M278m was funded by the government. Almost all of this is spent on antiretroviral medicines (ARVs). The remainder of the health budget comes from international donors. This includes programmes for HIV prevention, treatment and other supportive services. USAid and the CDC accounted for more than half the health budget last year, with the Global Fund contributing more than a fifth of the budget. Pepfar is a major contributor to the Global Fund. Terminated programmes HIV prevention services have been the worst affected by US aid cuts. M212.4m in USAid funds were earmarked for the SECURE project – an HIV prevention programme in 10 districts that included condom distribution, voluntary medical male circumcision, and pre-exposure prophylaxis (PrEP), said Turambiswa. A M168m project called Bophelo Bo Botle, supporting more than 120,000 people on ARVs was also terminated, despite a waiver protecting Pepfar's life-saving programmes, said Turambiswa. 'This is a treatment and care project whereby the Elizabeth Glaser Pediatric Aids Foundation deployed doctors, nurses, pharmacists, psychologists, counsellors, and the whole comprehensive list of human resources, putting them into ART clinics to see patients,' he said. A M78m project that was going to introduce long-acting PrEP injections, MOSAIC, was also ended. M90m for mental health and M77m for primary healthcare has also been cut. 'We have also lost support for pharmacy regulation, surveillance activities like mortality and drug resistance monitoring, community-led monitoring, and all quality assurance systems,' Turambiswa said. TB response falters The funding crisis is also derailing Lesotho's fight against TB, said Maama. While drugs and test kits are still available, outreach programmes have been put on hold. The World Health Organisation's Global TB Report 2024 estimates Lesotho's TB incidence at 664 cases per 100,000 people. About half of TB patients are also HIV-positive. Maama now warns that the situation is deteriorating. The Global Fund recently froze M19-million and suspended the full-scale rollout of its TB programme pending a funding model re-evaluation. 'We were scaling up community services to find every Mosotho with TB,' she said. She added that the freeze likely means a permanent loss even though the Global Fund used the word 'pause'. One suspended initiative, worth M4m, was set to upgrade TB wards in Mohale's Hoek and Leribe to serve as regional referral centres for drug-resistant TB.
